Latest posts
-
Dual Blockade in Diabetic Kidney Disease: Early Evidence Supports Combined Finerenone and Empagliflozin Therapy
Keywords: Chronic Kidney Disease, Diabetic Nephropathy, Finerenone, Empagliflozin, SGLT2 inhibitors, Mineralocorticoid Receptor Antagonist, CONFIDENCE study The management of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM) remains a growing clinical challenge, with substantial morbidity, mortality, and healthcare costs. While standard therapies—such as renin-angiotensin system (RAS) inhibitors—slow disease progression, residual risk remains…